Eisner et al reported the Severity of Asthma (SOA) score for patients with moderate to severe persistent asthma. It can help to identify a patient at increased risk for adverse clinical outcomes. The authors are from Genetech, Inc, in San Francisco.
Parameters:
(1) symptoms during the past 2 weeks
(2) use of systemic corticosteroids ever
(3) use of systemic corticosteroids in past year
(4) use of systemic corticosteroids >= 3 months during the past 2 years
(5) use of inhaled beta-agonists (SABA/LABA) during the past 2 weeks
(6) inhaled corticosteroids (ICS) by metered dose inhaler during the past 2 weeks
(7) cromolyn/nedocromil during the past 2 weeks
(8) anticholinergic therapy during the past 2 weeks
(9) theophylline, oral beta-agonist or leukotriene modifier during the past 2 weeks
(10) antihistamine, decongestant or nasal spray during the past 2 weeks
(11) home nebulizer use during the past 2 weeks
(12) ever hospitalized for asthma
(13) ever intubated for asthma
|
Parameter |
Finding |
Points |
|
symptoms |
none |
0 |
|
|
minimal |
1 |
|
|
occasional |
2 |
|
|
most days or nights |
3 |
|
|
every day or night |
4 |
|
systemic corticosteroids ever |
no |
0 |
|
|
yes |
2 |
|
systemic corticosteroids in past year |
no |
0 |
|
|
yes |
2 |
|
systemic corticosteroids >= 3 months in past 2 years |
no |
0 |
|
|
yes |
3 |
|
inhaled beta-agonists |
none |
0 |
|
|
< 2 puffs per day |
1 |
|
|
>= 2 puffs per day |
2 |
|
ICS |
none |
0 |
|
|
< 20 puffs per day |
1 |
|
|
>= 20 puffs per day |
2 |
|
cromolyn/nedocromil |
no |
0 |
|
|
yes |
1 |
|
anticholinergic therapy |
no |
0 |
|
|
yes |
1 |
|
theophylline, oral beta-agonist, leukotriene modifier |
no |
0 |
|
|
yes |
1 |
|
antihistamine, decongestant or nasal spray |
no |
0 |
|
|
yes |
1 |
|
home nebulizer |
no |
0 |
|
|
yes |
1 |
|
ever hospitalized for asthma |
no |
0 |
|
|
yes |
3 |
|
ever intubated for asthma |
no |
0 |
|
|
yes |
5 |
total score =
= SUM(points for all 13 parameters)
Interpretation:
• minimum score: 0
• maximum score: 28
• The higher the score the more severe the asthma and the worse the clinical outcomes.
Specialty: Pulmonology, Pedatrics, Emergency Medicine
